WALTHAM, Mass.--(PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook (ELN) solutions for laboratories performing routine analysis in multiple industries.)--
“This acquisition successfully positions PerkinElmer as the only technology provider able to deploy an optimized ELN solution across a global customer’s entire value chain, from research to manufacturing.”
The Labtronics acquisition follows the recent purchase of informatics companies CambridgeSoft and ArtusLabs by PerkinElmer, both announced in March. The addition of Labtronics’ solutions extends PerkinElmer’s ELN and data integration software offerings into laboratories following strict routine procedures, such as regulated and non-regulated QA/QC, late stage product or method development laboratories, and environmental and food testing labs. Labtronics tools can be applied to any procedure-based problem, including laboratory analysis, equipment calibration and validation, cleaning validation and others.
Founded in 1986, Labtronics’ products include its Nexxis ELN™ (Electronic Laboratory Notebook) for quality control (QC) and R&D and its Nexxis iLAB™ laboratory automation platform. The company is a leader in lab connectivity, directly connecting data from instrumentation to a lab’s ELN, SDMS, LIMS, ERP and SAP technologies for complete interface solutions. Labtronics’ LimsLink™ fully configurable lab integration software platform speeds deployment of new informatics systems and enhances the capabilities of existing system investments.
“We welcome the addition of Labtronics to PerkinElmer’s growing portfolio of informatics and software solutions for laboratory environments, as we enhance the Company’s strategic focus on enterprise-wide knowledge sharing and access,” said Dusty Tenney, president, Analytical Sciences and Laboratory Services, PerkinElmer, Inc. “This acquisition successfully positions PerkinElmer as the only technology provider able to deploy an optimized ELN solution across a global customer’s entire value chain, from research to manufacturing.”
He added, “The acquisition presents strong synergies with our OneSource® Laboratory Services portfolio providing enterprise-level solutions that foster long term partnerships with customers.”
Factors Affecting Future Performance
This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities and divestitures. Words such as "believes," "intends," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) markets into which we sell our products declining or not growing as anticipated; (2) fluctuations in the global economic and political environments; (3) our failure to introduce new products in a timely manner; (4) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable, or successfully divest businesses; (5) our failure to adequately protect our intellectual property; (6) the loss of any of our licenses or licensed rights; (7) our ability to compete effectively; (8) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (9) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (10) disruptions in the supply of raw materials and supplies; (11) the manufacture and sale of products exposing us to product liability claims; (12) our failure to maintain compliance with applicable government regulations; (13) regulatory changes; (14) our failure to comply with healthcare industry regulations; (15) economic, political and other risks associated with foreign operations; (16) our ability to retain key personnel; (17) significant disruption in our information technology systems; (18) restrictions in our credit agreements; (19) our ability to realize the full value of our intangible assets; (20) significant fluctuations in our stock price; (21) reduction or elimination of dividends on our common stock; and (22) other factors which we describe under the caption "Risk Factors" in our most recent annual report on Form 10-K and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.
About Labtronics Inc.
Labtronics Inc. is a world leader in providing data integration solutions for laboratories in multiple industries. Combining an expertise in instrument integration and workflow automation allows Labtronics to deliver innovative solutions to solve the demanding needs of today’s customers. For more information, please visit: www.labtronics.com.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $1.7 billion in 2010, has about 6,200 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.